Mead Johnson From the Inside
James Cornelius, chairman of the board at Mead Johnson Nutrition (MJN), directly purchased 10,000 shares of the company's stock on Oct. 31st at an average price of $61.75 per share, according to a filing with the Securities and Exchange Commission.
Mead Johnson Nutrition is a $13 billion market-cap company that manufactures infant formula and other milk products. According to our database of filings regarding insider purchases and sales, Cornelius has bought shares of Mead Johnson at various points since its spinout from Bristol-Myers Squibb (BMY) in February 2009. Since then, the stock has risen a total of 137% while the S&P 500 has roughly doubled. But the stock is down since Cornelius's three previous buys (research Cornelius's insider purchasing activity). After this purchase, he owns almost 100,000 shares of the company....550 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.
